STCG
MD icon

Speece Thorson Capital Group’s Pediatrix Medical MD Stock Holding History

Speece Thorson Capital Group’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-53,317
Closed -$3.87M – 41
2015
Q1 		$3.87M Buy
53,317
+850
+2% +$59.1K 0.91% 39
2014
Q4 		$3.47M Buy
+52,467
New +$3.2M 0.84% 38

Other funds holding MD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Speece Thorson Capital Group's MD Position: Q2 2015 in Review

Speece Thorson Capital Group sold out of Pediatrix Medical (MD) in Q2 2015, closing a stake of 53,317 shares — an estimated $3.87M sold.

Speece Thorson Capital Group first reported a position in MD in Q4 2014 and held it in 2 quarters. The position peaked at $3.87M in Q1 2015. 355 funds tracked by Wall St. Rank hold MD as of Q2 2015.

  • Speece Thorson Capital Group reported no remaining Pediatrix Medical position as of Q2 2015 after selling out during the quarter.
  • Speece Thorson Capital Group sold 53,317 Pediatrix Medical shares in Q2 2015, an estimated $3.87M.
  • Speece Thorson Capital Group first reported a position in Pediatrix Medical in Q4 2014 and held it in 2 quarters.
  • Speece Thorson Capital Group's Pediatrix Medical position peaked at $3.87M in Q1 2015.
  • 355 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2015.

Based on Speece Thorson Capital Group's 13F filing for Q2 2015, filed 27 Jul 2015.